American Society of Ketamine Physicians

American Society of Ketamine Physicians The group is for ASKP3 members to connect, share and grow in the ketamine community.

Speaker Highlight: Christine Pateros, MA, RNJoin us at the 2026 ASKP3 Annual Conference as we welcome Christine Pateros,...
12/19/2025

Speaker Highlight: Christine Pateros, MA, RN

Join us at the 2026 ASKP3 Annual Conference as we welcome Christine Pateros, MA, RN, a global spiritual guide, ceremonialist, psychedelic-assisted nurse therapist, healer, and Training Director for PRATI's research End-of-Life Psychedelic-Assisted Therapy Training.

Christine’s presentation explores ketamine therapy as a supportive tool for those facing end-of-life or existential distress. She will walk attendees through mindset considerations, safety, potential benefits, and real case studies that illuminate the profound possibilities of this work.

Rooted in ecocentric ritual and guided by her lived experience, lineage, and decades of service, Christine brings a deeply grounded and compassionate perspective to conscious living and dying practices.

2026 ASKP3 Annual Conference
Austin Marriott Downtown
January 29–31, 2026

🌟 Speaker & Session Spotlight: Muhammad (Asad) Khan, MBBS, & Amna Aslam, MBA, MSc 🌟We’re excited to welcome Asad Khan an...
12/17/2025

🌟 Speaker & Session Spotlight: Muhammad (Asad) Khan, MBBS, & Amna Aslam, MBA, MSc 🌟

We’re excited to welcome Asad Khan and Amna Aslam to the ASKP3 2026 Annual Conference. Together they bring deep expertise in neuromodulation, ketamine therapy, TMS, and outcomes-based psychiatric research.

Their featured study examines the combined use of the PHQ-9 and DSM-5 Cross-Cutting Symptom Measure to track outcomes in patients with treatment-resistant depression receiving Spravato. In a real-world sample, the multidimensional approach captured meaningful clinical improvements not identified by the PHQ-9 alone — offering a more complete picture of patient response, especially in the presence of comorbidities.

Amna will also lead additional sessions exploring IV ketamine outcomes and clinical practice patterns in ketamine therapy, making this a must-attend session for clinicians focused on evidence, safety, and innovation.

2026 ASKP3 Annual Conference
📍 Austin Marriott Downtown
📅 January 29–31, 2026

Speaker & Session Highlight: Wilhelmina De Castro, LCSW, with Opening Remarks by Meredith Thomas, Co-Executive Director ...
12/12/2025

Speaker & Session Highlight: Wilhelmina De Castro, LCSW, with Opening Remarks by Meredith Thomas, Co-Executive Director of Thank You Life

Join us at the 2026 ASKP3 Annual Conference for an insightful session designed to strengthen the foundations of group ketamine-assisted psychotherapy!

Guided by Wilhelmina De Castro, LCSW, and framed by opening remarks from Meredith Thomas, this presentation explores trauma-informed principles that support safe, inclusive, and healing-centered group KAP environments.

Clinicians will walk away with practical tools, grounded methodology, and approaches that nurture co-regulation, connection, and ethical group facilitation.

📍 Austin Marriott Downtown
📅 January 29–31, 2026

🌟 Speaker Highlight: Dr. Bruce Nadro 🌟At the 2026 ASKP3 Annual Conference, Dr. Nadro will present two sessions that brin...
12/12/2025

🌟 Speaker Highlight: Dr. Bruce Nadro 🌟

At the 2026 ASKP3 Annual Conference, Dr. Nadro will present two sessions that bring forward some of the most exciting advancements in ketamine-assisted psychotherapy.

One session breaks down eight physiological interventions that can enhance ketamine’s neuroplasticity window and improve treatment outcomes. Attendees will gain clarity on modalities like vagus nerve stimulation, red light therapy, neurofeedback, and hyperbaric oxygen, including their mechanisms, evidence base, and integration into clinical practice.

His second focus explores AI-driven treatment matching and biologically informed care, offering a framework for personalized mental health support through biomarkers and evidence-supported adjunct therapies.

Join us in Austin to learn how these approaches can strengthen and extend therapeutic benefits for patients.

📍 Austin Marriott Downtown
📅 January 29–31, 2026

12/09/2025

Safety. Excellence. Innovation.
Join us in Austin as we build the Gold Standard in ketamine therapy.
Jan 29–31, 2026
Learn more: askp.org/annual-conference-attendees

The countdown is on for the 2026 ASKP3 Annual Conference — the premier gathering for clinicians, researchers, and innova...
11/25/2025

The countdown is on for the 2026 ASKP3 Annual Conference — the premier gathering for clinicians, researchers, and innovators shaping the future of ketamine and psychedelic-assisted therapies.

📅 January 29–31, 2026
📍 Austin Marriott Downtown

Focused on the theme, “Building the Gold Standard: Advancing Excellence in Ketamine Therapy and Informing the Psychedelic Future,” this year's Conference invites you to join a community dedicated to setting the benchmark for safe, effective, and ethical care.

What to Expect:
📌 19+ hours of CME/CE-accredited sessions (pending approval);
📌 Scientific and clinical presentations exploring evidence-based applications and emerging models of care;
📌 Peer-reviewed abstracts highlighting new research and real-world innovation; and
📌 Exhibit hall access to the latest tools, technologies, and practice solutions.

Learn more and register at: https://askp.org/annual-conference-attendees/

Good news! We’ve extended the registration discount to Monday, December 1 but this will be your last chance to save! Ear...
11/22/2025

Good news! We’ve extended the registration discount to Monday, December 1 but this will be your last chance to save! Early-bird pricing for the 2026 ASKP3 Annual Conference ends TODAY! Don't wait, time is runing out!

Join us January 29–31, 2026, in Austin, TX, for three days of cutting-edge sessions, networking, and the latest insights in ketamine and emerging treatments. Register now and save $100 before prices go up! ASKP3 members receive additional discounts. Secure your spot—and your room at the discounted ASKP rate—while availability lasts!
Register now: https://askp3.memberclicks.net/2026annual

11/19/2025

The 2026 ASKP3 Annual Conference is where the brightest minds, strongest data, and most forward-thinking conversations in ketamine therapy come together.

Austin, TX • Jan 29–31
Be part of the team building the Gold Standard.

⏰ Last chance to save! Early-bird pricing for the 2026 ASKP3 Annual Conference ends TODAY!Join us January 29–31, 2026, i...
11/14/2025

⏰ Last chance to save! Early-bird pricing for the 2026 ASKP3 Annual Conference ends TODAY!

Join us January 29–31, 2026, in Austin, TX, for three days of cutting-edge sessions, networking, and the latest insights in ketamine and emerging treatments. Register now and save $100 before prices go up!

ASKP3 members receive additional discounts. Secure your spot—and your room at the discounted ASKP rate—while availability lasts!

Register now: https://askp3.memberclicks.net/2026annual

Be part of the movement shaping the future of ketamine and psychedelic medicine! 🌟ASKP3 is now welcoming exhibitors and ...
11/14/2025

Be part of the movement shaping the future of ketamine and psychedelic medicine! 🌟

ASKP3 is now welcoming exhibitors and sponsors for the 2026 Annual Conference—January 29–31 in Austin, TX. Join top clinicians, researchers, and innovators for three days of connection, collaboration, and cutting-edge insights.

Showcase your products, elevate your brand, and build meaningful partnerships with leaders guiding the next era of ketamine and psychedelic-assisted care.

✨ Spaces are limited—secure your exhibit or sponsorship today at https://askp.org/annual-conference-exhibits-and-sponsors/

Join us for our next upcoming session in the Meet the Expert webinar series, The Role of Ketamine in the World of Psyche...
11/10/2025

Join us for our next upcoming session in the Meet the Expert webinar series, The Role of Ketamine in the World of Psychedelics, led by Scott Shannon, MD, on Monday, November 17, at 8:30 p.m. ET.

This FREE webinar series is a fantastic opportunity for ASKP3 members to connect with experts, gain insight into new academic and clinical research, discuss challenging cases, and dive deep into specialized topics. One of our Expert Faculty will guide each session, providing valuable knowledge you won’t want to miss. Additionally, registrants of the webinar receive recording access for one (1) year post-event, for on-demand refresh and review of webinar content.

Non-members are welcome to attend this webinar for just $35.00 USD.

Click below to register for The Role of Ketamine in the World of Psychedelics, with Scott Shannon, MD, now!

https://askp3.memberclicks.net/nov2025webinar #/

Have you heard concerns around bladder damage or cognitive damage related to ketamine use? While it’s possible for this ...
11/07/2025

Have you heard concerns around bladder damage or cognitive damage related to ketamine use? While it’s possible for this to occur, we’d like to share under what circumstances and dosing range this typically happens! Like most things the AMOUNT and ROUTE of administration of any substance matters. There can be too much of a good thing!

Prior research has shown, that people who abuse ketamine on their own in very high doses, such as 1000 mg per day over many months or years, will likely end up with significant bladder or cognitive damage among other problems. This is very different than supervised medical administration of ketamine, which does not come anywhere near these kinds of doses. Ketamine infusions for depression use significantly lower doses, such as around 50 mg twice a week for several weeks and then usually around once a month for maintenance. For perspective, the average person being treated for depression would receive about the same amount of ketamine spread out over a year, as someone abusing it might use on a single day, and then continue using that daily.

After 10 years of data and clinical experience, we are not seeing these kinds of complications in the real world.

Pursuing ketamine treatments provided in a licensed clinical setting by prescription, is a safe method of delivery that allows clinicians to track a total safe amount for their patients which avoids these types of complications.

Address

222 S. Westmonte Drive, Suite 111
Altamonte Springs, FL
32714

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Alerts

Be the first to know and let us send you an email when American Society of Ketamine Physicians posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to American Society of Ketamine Physicians:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram